SYNCHRON SYSTEMS BENZODIAZEPINE (BNZG) REAGENT

Enzyme Immunoassay, Benzodiazepine

BECKMAN COULTER, INC.

The following data is part of a premarket notification filed by Beckman Coulter, Inc. with the FDA for Synchron Systems Benzodiazepine (bnzg) Reagent.

Pre-market Notification Details

Device IDK043556
510k NumberK043556
Device Name:SYNCHRON SYSTEMS BENZODIAZEPINE (BNZG) REAGENT
ClassificationEnzyme Immunoassay, Benzodiazepine
Applicant BECKMAN COULTER, INC. 200 SOUTH KRAEMER BLVD. W-110 Brea,  CA  92822
ContactAnnette Hellie
CorrespondentAnnette Hellie
BECKMAN COULTER, INC. 200 SOUTH KRAEMER BLVD. W-110 Brea,  CA  92822
Product CodeJXM  
CFR Regulation Number862.3170 [🔎]
DecisionSubstantially Equivalent (SESE)
TypeTraditional
3rd Party ReviewedNo
Combination ProductNo
Date Received2004-12-27
Decision Date2005-03-28
Summary:summary

NIH GUDID Devices

Device IdentifiersubmissionNumberSupplement
15099590202026 K043556 000

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.